Metabolic imbalances in the skeletal muscle are mediated by tumour-derived pro-inflammatory cytokines, such as tumour necrosis factor-α (TNF-α), interleukin-1 (IL-1), IL-6, and transforming growth factor β1 (TGFβ1) [5]. This evidence concerns the gene IL1B and neoplasm.